Single‑Molecule Mass Spectrometry of Proteins: Insights from a Recent U.S. Patent Application
Understanding how a new patent application aims to push protein analysis beyond ensemble averages
Introduction
Mass spectrometry (MS) has long been the workhorse for identifying and quantifying proteins, yet conventional instruments measure signals from billions of ions simultaneously. Here's the thing — s. patent application** (Publication No. Think about it: US2023/0184567 A1, filed March 2022) proposes a single‑molecule mass spectrometry (smMS) platform specifically designed for proteins. A recent **U.This ensemble approach masks heterogeneity that can be biologically crucial—such as sub‑populations of post‑translationally modified isoforms, misfolded species, or low‑abundance biomarkers. The invention combines nanopore‑based ion detection with cryogenic ion trapping to achieve mass resolution at the level of individual protein molecules Practical, not theoretical..
This article walks through the technical background, the core innovations disclosed in the application, the scope of the claimed invention, and the potential impact on biomedical research and diagnostics.
1. Technological Context
1.1 Why Single‑Molecule Detection Matters
- Heterogeneity resolution – Traditional MS averages over millions of ions, obscuring minor species that may represent disease‑specific states.
- Dynamic range expansion – Detecting a single molecule pushes the lower detection limit far below the attomole regime, enabling analysis of scarce samples (e.g., single‑cell lysates).
- Reduced sample consumption – Because each measurement uses only one ion, precious biological material is conserved.
1.2 Limitations of Existing Approaches
| Approach | Typical Detection Limit | Main Drawback for Proteins |
|---|---|---|
| Electrospray ionization (ESI)‑TOF/Orbitrap | ~10⁻¹⁸ mol (zeptomole) | Requires ion averaging; cannot resolve single‑molecule mass shifts |
| MALDI‑TOF | ~10⁻¹⁵ mol | Matrix interference; poor for large, heterogeneous proteins |
| Nanopore ionic current sensing | ~single molecule | Measures size/charge, not exact mass; limited mass resolution |
| Cryogenic ion trapping (CIT) | ~10⁻¹⁸ mol | Still ensemble‑based; trapping efficiency low for large biomolecules |
The patent application seeks to overcome these shortcomings by merging the mass‑analysis strength of cryogenic ion traps with the single‑entity sensitivity of solid‑state nanopores Not complicated — just consistent..
2. Core Invention Disclosed in the Application
2.1 Overview of the smMS Platform
The disclosed system consists of three coupled modules:
- Soft Ionization Source – A modified electrospray nozzle operating at low temperature (‑20 °C) to generate intact protein ions with minimal fragmentation.
- Cryogenic Linear Ion Trap (cLIT) – A quadrupole trap housed inside a 4 K helium cryostat, where ions are cooled to near‑ground vibrational states, sharpening their mass‑to‑charge (m/z) peaks.
- Solid‑State Nanopore Detector – A silicon nitride membrane with a sub‑5 nm pore, biased to drive individual ions through the aperture while measuring transient ionic current blockades.
As a single protein ion traverses the nanopore, its mass‑dependent dwell time and current signature are recorded. Because the ion’s kinetic energy is well‑defined by the cryogenic trap, the dwell time can be converted directly into an accurate mass value (via calibrated mobility‑mass relationships) Small thing, real impact..
2.2 Key Innovations
| Innovation | How It Improves smMS | Patent Claim Highlight |
|---|---|---|
| Temperature‑matched ion source & trap | Reduces internal energy, preserving labile PTMs and preventing adduct formation that would broaden peaks. ” | |
| Real‑time deconvolution algorithm | Converts raw current blockades into mass spectra on‑the‑fly, correcting for drift and noise using a hidden‑Markov model. On top of that, ” | |
| Nanopore with functionalized inner surface | Allows reversible binding of a short peptide “mass tag” that shifts the ion’s mobility in a predictable way, enabling internal calibration for each translocation event. | Claim 4: “Applying a composite RF waveform comprising a fundamental frequency and a second harmonic to the quadrupole rods.” |
| Dual‑frequency trapping waveform | Enhances confinement of high‑mass (>150 kDa) proteins while suppressing secular motion that leads to ion loss. On the flip side, | Claim 1: “An electrospray ion source operated at a temperature between ‑30 °C and 0 °C, coupled to a cryogenic ion trap maintained at ≤10 K. Now, |
These features collectively address the three main bottlenecks identified in prior work: ion fragmentation, insufficient trapping efficiency for high‑mass analytes, and lack of an internal mass reference for each event.
2.3 Example Embodiment (Figure‑Based Description)
Although the patent text includes several figures, the core embodiment can be summarized as follows:
- A nano‑ESI emitter (tip radius ~1 µm) sprays a protein solution (e.g., ubiquitin, 8.6 kDa) mixed with a volatile additive (e.g., supercharging reagent) at ‑15 °C.
- Ions are guided through an ion funnel into the cLIT, where a 2 MHz fundamental RF plus a 4 MHz second harmonic creates a pseudopotential well deep enough to hold ions up to 500 kDa.
- After a variable storage time (10–500 ms), ions are ejected axially toward a silicon nitride nanopore (diameter 3 nm, length 10 nm) positioned 100 µm from the trap exit.
- A bias of ±200 mV drives the ion through the pore; the resulting current dip lasts from 5 µs (for small peptides) to >150 µs (for large antibodies).
- The digitized trace is fed to an FPGA that runs the deconvolution algorithm, outputting a mass estimate with a reported standard deviation of <0.5 % for intact proteins under 200 kDa.
3. Scope of the Claims
The application contains 20 independent claims and
The application contains 20 independent claims and numerous dependent claims that further define the invention's scope. The independent claims are organized around the core inventive concepts:
- Claim 1 defines the system comprising the cooled electrospray ion source and the cryogenic linear ion trap.
- Claim 4 covers the method of using a dual-frequency trapping waveform for enhanced confinement of high-mass ions.
- Claim 7 is directed to the functionalized nanopore with a mass tag for internal calibration.
- Claim 12 defines the processor executing the real-time deconvolution algorithm based on a hidden Markov model.
Dependent claims add further specificity, such as particular temperature ranges, RF frequencies, nanopore materials, and details of the deconvolution process. This layered claim strategy provides dependable protection for the integrated system, its key components, and the data processing method.
4. Conclusion
The disclosed invention presents a significant advancement in mass spectrometry by directly addressing the fundamental challenges of analyzing large, intact protein complexes. By integrating a cooled ion source for reduced fragmentation, a specialized dual-frequency ion trap for efficient high-mass confinement, a functionalized nanopore for single-molecule event calibration, and a sophisticated real-time data processing algorithm, the system achieves a synergistic improvement in accuracy, speed, and applicability. The claimed invention is not merely a collection of individual improvements but a cohesive, end-to-end solution for top-down mass spectrometry, enabling the precise characterization of proteins and their complexes that were previously inaccessible with conventional techniques The details matter here..
The application contains 20 independent claims and numerous dependent claims that further define the invention's scope. The independent claims are organized around the core inventive concepts:
- Claim 1 defines the system comprising the cooled electrospray ion source and the cryogenic linear ion trap.
- Claim 4 covers the method of using a dual-frequency trapping waveform for enhanced confinement of high-mass ions.
- Claim 7 is directed to the functionalized nanopore with a mass tag for internal calibration.
- Claim 12 defines the processor executing the real-time deconvolution algorithm based on a hidden Markov model.
Dependent claims add further specificity, such as particular temperature ranges, RF frequencies, nanopore materials, and details of the deconvolution process. This layered claim strategy provides reliable protection for the integrated system, its key components, and the data processing method.
4. Broader Implications and Future Directions
The integration of these advanced components opens new avenues for research in structural biology, proteomics, and drug discovery. By enabling the routine analysis of intact protein complexes up to 500 kDa, the system allows for the study of quaternary structures, large-scale conformational changes, and the composition of transiently assembled complexes that are often critical to biological function. The high mass accuracy and speed of the technique make it particularly suited for screening large libraries of candidate therapeutics, such as antibodies and antibody-drug conjugates, where precise characterization of the intact molecule is key.
To build on this, the real-time, single-molecule nature of the nanopore detection offers a unique opportunity to observe dynamic processes. Potential future iterations could incorporate optical or electronic triggers to initiate specific reactions within the trap, allowing for the study of protein folding, unfolding, or complex assembly pathways in real time. The platform's modular design also suggests possibilities for coupling with other analytical techniques, such as ion mobility spectrometry, to add another dimension of separation and structural information Worth keeping that in mind..
5. Conclusion
At the end of the day, the disclosed invention represents a paradigm shift in top-down mass spectrometry. It successfully overcomes the long-standing limitations of ion trapping and detection for high-mass biomolecules through a synergistic combination of innovations: a cooled source to preserve native structures, a specialized trap to confine massive ions, a calibrated nanopore for precise translocation event measurement, and an intelligent algorithm to interpret the data. This end-to-end solution provides researchers with a powerful new tool to probe the architecture and dynamics of the proteome at a scale and with a precision previously unattainable. The solid claim set secures the core technology while leaving room for future development, positioning this system as a foundational platform for the next generation of biomolecular analysis.
